{
    "code": "01055555",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01055555",
    "time": "2018-02-23 03:19:00",
    "許可證字號": "衛署藥製字第055555號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "109\/11\/24",
    "發證日期": "99\/11\/24",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00105555501",
    "中文品名": "“培力”安諾妥膜衣錠 1 毫克",
    "英文品名": "Anotrole F.C. Tablets 1mg“P.L.”",
    "適應症": "治療停經後婦女晚期乳癌。其療效對於雌激素接受器陰性之病患尚未被證實，除非這些病患曾經對TAMOXIFEN有陽性反應。輔助治療停經後婦女且荷爾蒙接受器為陽性的早期侵犯性乳癌。輔助治療已使用tamoxifen 2-3年之停經後婦女且荷爾蒙接受器為陽性的早期乳癌。",
    "劑型": "116膜衣錠",
    "包裝": "2~1000粒鋁箔盒裝 2~1000粒塑膠瓶裝",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "主成分略述": [
        "ANASTROZOLE"
    ],
    "限制項目": "01國　產 24監視期滿學名藥 61完成BE試驗",
    "申請商名稱": "1112209200  培力藥品工業股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1112209300  培力藥品工業股份有限公司",
        "製造廠廠址": "台中市西屯區工業區六路１１號",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004001800",
            "成分名稱": "ANASTROZOLE",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "ANT-D_02-106-08-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055555&Seq=005&Type=9"
        },
        {
            "title": "衛署藥製字第055555號-ANT-PTP(new)-105-11-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01055555&Seq=007&Type=8"
        }
    ]
}